Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13-Reference-Cited by-同舟云学术

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13

Published:2007-02 Issue:3 Volume:136 Page:451-461
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Scully Marie,Cohen Hannah,Cavenagh Jamie,Benjamin Sylvia,Starke Richard,Killick Sally,Mackie Ian,Machin Samuel J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06448.x/fullpdf

Reference35 articles.

1. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)

2. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

3. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

4. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome;Blood;2024-09-12

2. Lupus nephritis. Part II, modern ideas about therapy;Rheumatology Science and Practice;2024-09-02

3. KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Translated into Russian by E.V. Zakharova;Nephrology and Dialysis;2024-08-13

4. Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura;Blood;2024-06-20

5. Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura;Annals of Hematology;2024-04-27